ECRM_1170x120_8-1-17

Optum

Former GSK CEO chosen to head Optum

MINNEAPOLIS — UnitedHealth Group has tapped former GlaxoSmithKline PLC (GSK) chief executive officer Sir Andrew Witty as the next CEO of Optum, its health services, technology and pharmacy benefits management unit. The appointment is effective July 1. Witty, 53, will succeed Larry Renfro, who is set to lead UnitedHealth Group’s enterprise growth efforts and Optum’s

Ex-GSK CEO Andrew Witty to take helm at Optum

Ex-GSK CEO Andrew Witty to take helm at Optum

MINNEAPOLIS — Former GlaxoSmithKline plc chief executive officer Sir Andrew Witty has been named CEO of Optum, the health services, technology and pharmacy benefits management unit of health insurance giant UnitedHealth Group. Plans call for Witty to start as Optum CEO on July 1. He takes over from Larry Renfro, vice chair of UnitedHealth Group, who has

PBMs OptumRx, Catamaran to merge in $12.8 billion deal

PBMs OptumRx, Catamaran to merge in $12.8 billion deal

NEW YORK and SCHAUMBURG, Ill. — Reflecting the ongoing consolidation in the pharmacy benefit management (PBM) sector, UnitedHealth Group plans to acquire Catamaran Corp. in a deal valued at $12.8 billion. The companies said Monday that Catamaran would integrated into OptumRx, UnitedHealth’s freestanding pharmacy care services business and part of its Optum health services unit.